PedAM
Pediatric Disease Annotations & Medicines
| Disease | gastric cancer |
| Symptom | C0686619|lymph node metastases |
| Sentences | 29 |
| PubMedID- 22843926 | Thus, the combination of psk with oral chemotherapeutic agents might be suitable for postoperative adjuvant therapy against gastric cancer in patients with lymph node metastases. |
| PubMedID- 22167664 | We have already described the feasibility and efficacy of preoperative chemotherapy using dcs therapy in gastric cancer patients with para-aortic lymph node metastases (8). |
| PubMedID- 22154885 | Methods: we enrolled patients with initially unresectable locally advanced gastric cancer because of severe lymph node metastases or invasion of adjacent structures. |
| PubMedID- 23382154 | A prognostic biomarker for gastric cancer with lymph node metastases. |
| PubMedID- 25605147 | In the current study, we aimed to determine the cause of discordance in her-2 expression in the primary tumor and lymph node metastases for patients with gastric cancer. |
| PubMedID- 21443137 | Thus, neoadjuvant chemotherapy described here may be rather promising regimen for advanced gastric cancer with para-aortic lymph node metastases, considering its low grade toxicities and pathological responses. |
| PubMedID- 22202307 | Case 3: a 72-year-old male diagnosed as having stage iv gastric cancer with liver and lymph node metastases underwent a wds placement during the first-line chemotherapy. |
| PubMedID- 20567117 | In advanced gastric cancer with para-aortic lymph node metastases without other non-curative factors, long-term survival can be expected by combining a curative operation with s-1/cddp combined therapy. |
| PubMedID- 21666553 | Conclusion: n ratio is useful to better evaluate the status of lymph node metastases in patients with gastric cancer submitted to radical surgery. |
| PubMedID- 25622826 | Decreased concentrations of pfaas were associated with lymph node metastases in gastric cancer. |
| PubMedID- 25721950 | A recent study identified six mirnas significantly increased in lymph node metastases of gastric cancer: mir-21, mir-27a, mir-106b, mir-146a, mir-148a and mir-223 . |
| PubMedID- 20087051 | Case 2: a 53-year-old man underwent palliative gastrectomy for advanced type 3 gastric cancer with multiple lymph node metastases involving virchow's metastases. |
| PubMedID- 22553412 | The suspected diagnosis was malignant gastric cancer with lymph node metastases. |
| PubMedID- 25731494 | A case report of advanced gastric cancer with bulky lymph node metastases successfully treated with induction chemotherapy followed by curative resection. |
| PubMedID- 20414031 | A case of advanced gastric cancer with distant lymph node metastases in cervical, supraclavicular and superior mediastinum successfully treated with s-1/cisplatin (cddp)/lentinan combination chemotherapy. |
| PubMedID- 22500260 | The characteristics of early gastric cancer patients with lymph node metastases have been reported in many institutions, but the appropriate extent of lymph node dissection for early gastric cancer remains controversial. |
| PubMedID- 25872022 | Advanced gastric cancer with liver and lymph node metastases successfully resected after induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil. |
| PubMedID- 21874426 | Since the disease was far advanced esophagogastric cancer with marked lymph node metastases throughout the mediastinum, curative resection would have been unlikely. |
| PubMedID- 25731542 | Herein, we report of a patient who underwent r0 resection for gastric cancer with no.16 lymph node metastases and who achieved long-term survival. |
| PubMedID- 25911901 | Conclusions: her2 overexpression was seen in one-third of primary gastric cancers with lymph node metastases. |
| PubMedID- 23863661 | A case of advanced gastric cancer with bulky lymph node metastases responding to s-1/cddp neoadjuvant chemotherapy and leading to less invasive surgery and a pathologically complete response. |
| PubMedID- 24917013 | A case of advanced gastric cancer with para-aortic lymph node metastases responding to s-1/cddp chemotherapy that leads to a pathological complete response. |
| PubMedID- 26479552 | Background: the incidence of pathological lymph node metastases in patients with gastric cancer is 5% to 10%, which means that approximately 90% of patients with gastric cancer may undergo unnecessary lymphadenectomy. |
| PubMedID- 23743877 | Conclusion: the osna assay can detect lymph node metastases in gastric cancer patients as accurately as the histological examination of blocks sectioned at 2-mm intervals. |
| PubMedID- 21689422 | Furthermore, a higher frequency of erbb2 and egfr gene amplification is present in gastric cancer patients with lymph node metastases. |
| PubMedID- 21661446 | Prognostic significance of a new system for categorization of the number of lymph node metastases in gastric cancer. |
| PubMedID- 24998731 | A man in 60s underwent total gastrectomy for advanced gastric cancer with para-aortic lymph node metastases. |
| PubMedID- 25620172 | Furthermore, decreased expression of mir-133a and increased expression of tagln2 were both associated with lymph node metastases in patients with gastric cancer (p<0.001; p=0.011). |
| PubMedID- 24889718 | gastric cancer with para-aortic lymph node metastases: do not miss a chance of cure. |
Page: 1